FDA Warning Letter
J. Moniz Company Inc.
Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions
- 発出日
- 2024.08.07
- 掲載日
- 2024.08.27
- 発行オフィス
- Division of Northeast Imports
- MARCS-CMS 番号
- 689905
- 配達方法
- VIA EMAIL AND UNITED PARCEL SERVICE
- 宛先
- Joao Moniz
本文(英語原文)
- Delivery Method:
- VIA EMAIL AND UNITED PARCEL SERVICE
- Product:
- Food & Beverages
- Recipient:
-
Recipient NameJoao Moniz
-
Recipient TitlePresident
- J. Moniz Company Inc.
91 Wordell Street
Falls River, MA 02721-4307
United States
- Issuing Office:
- Division of Northeast Imports
United States
August 7, 2024
WARNING LETTER
RE: CMS# 689905
Dear Mr. Moniz:
We inspected your seafood importer establishment, located at 91 Wordell Street, Falls River, MA 02721-4307 on June 24, 2024. We found that you have serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations, Part 123 (21 CFR Part 123). The specific requirements for imported fish and fishery products are set out in 21 CFR 123.12. As an importer of fish or fishery products, you must operate in accordance with the requirements of Part 123. In accordance with 21 CFR 123.12(d), there must be evidence that all fish and fishery products offered for entry into the United States have been processed under conditions that comply with 21 CFR Part 123. If assurances do not exist that the imported fish or fishery product has been processed under conditions that are equivalent to those required of domestic processors under 21 CFR Part 123, the fish or fishery products will appear to be adulterated under Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 342(a)(4) and will be denied entry. Because our inspection identified serious violations for 21 CFR Part 123, your imported raw, fresh chilled, refrigerated skipjack bonito (Katsuwonus pelamis) and fresh, chilled sardines (Sardina pilchardus) from Portugal are adulterated under Section 402(a)(4)of the Act (21 U.S.C. § 342(a)(4)), in that they have been prepared, packed, or held under insanitary conditions whereby they may have been rendered injurious to health. You may find the Act, the seafood HACCP regulation and the Fish and Fisheries Products Hazards & Controls Guidance through links in FDA's home page at www.fda.gov.
Your significant violations were as follows:
1. You must implement an affirmative step which ensures that the fish and fishery product(s) you import are processed in accordance with the seafood HACCP regulation, to comply with 21 CFR 123.12(a)(2)(ii). However, your firm did not perform an affirmative step for raw, fresh, chilled, refrigerated skipjack bonito (Katsuwonus pelamis) and fresh, chilled sardines (Sardina pilchardus) manufactured by (b)(4) located in Portugal.
We may take further action if you do not promptly correct these violations. For instance, we may take further action to refuse admission of your imported fish or fishery products under Section 801(a) of the Act (21 U.S.C. § 381(a)), including placing them on "detention without physical examination," seize your product(s) and/or enjoin your firm from further violating the Act.
You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should outline the specific things you are doing to correct these violations. You should include in your response documentation, such as HACCP and importer verification records and records that document the performance and results of your firm’s affirmative steps, or other useful information that would assist us in evaluating your corrections. If you cannot complete all corrections before you respond, you should explain the reason for your delay and state when you will correct any remaining violations.
This letter may not list all the violations at your facility. You are responsible for ensuring that your seafood importer establishment operates in compliance with the Act and the seafood HACCP regulation (21 CFR Part 123). You also have a responsibility to use procedures to prevent further violations of the Act and all applicable regulations for the fish or fishery products that you import into the United States.
Please send your reply to the Food and Drug Administration, Attention: Feryal Ahmad, FDA Compliance Officer, Division of Northeast Imports: ORAOEIONEIMPORTSWLResponses@fda.hhs.gov. Please also cc (carbon copy) Feryal.Ahmad@fda.hhs.gov. If you have questions regarding any issues in this letter, please contact Compliance Officer Feryal Ahmad at Feryal.Ahmad@fda.hhs.gov. Please reference CMS# 689905 on any documents or records you provide to us and/or within the subject line of any email correspondence you send to us.
Sincerely,
/S/
CDR Joseph Tomao
Program Division Director
Division of Northeast Imports
出典: fda.gov(U.S. FDA)の Warning Letters 公開情報 (米国政府著作物としてパブリックドメイン)をそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。
Warning Letter の最新状態・Close-out(是正完了)の正は FDA 公式サイトです。是正が完了した企業には Close-out Letter が発行される場合があり、本サイトの表示が最新の状態を反映していないことがあります。掲載は事実の転載であり、企業の現在の法令遵守状況について評価・断定するものではありません。
取得日: 2026.08.20
各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。